Amgen Dividends and Buybacks
Dividend criteria checks 4/6
Amgen is a dividend paying company with a current yield of 3.13%. Next payment date is on 9th December, 2024 with an ex-dividend date of 18th November, 2024.
Key information
3.1%
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 3.1% |
| Future Dividend Yield | 3.6% |
| Dividend Growth | 4.0% |
| Next dividend pay date | 09 Dec 24 |
| Ex dividend date | 18 Nov 24 |
| Dividend per share | US$9.000 |
| Payout ratio | 113% |
Recent dividend and buyback updates
Recent updates
Amgen Sells Off: Keep Calm And Buy The Dip
Nov 18Amgen's (NASDAQ:AMGN) Problems Go Beyond Weak Profit
Nov 08
Amgen: A Biotech Giant Offering Value And Growth In A Frothy Market
Nov 03Amgen Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Nov 02Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The List
Oct 25Amgen: Pipeline Updates, Uplizna Performs And Rocatinlimab Underwhelms
Sep 26Amgen: Growth Is Still A Better Choice
Aug 28Amgen Inc. Just Missed EPS By 46%: Here's What Analysts Think Will Happen Next
Aug 09Amgen: Shows Why Dividend Investing Is Getting Tougher
Aug 07Amgen (NASDAQ:AMGN) Takes On Some Risk With Its Use Of Debt
Jul 26The Price Is Right For Amgen Inc. (NASDAQ:AMGN)
Jul 11Amgen: An Emerging GLP-1 Play, Modest Mid-Teens P/E With Strong Momentum
Jul 05Amgen: You Haven't Seen Anything Yet
Jun 17Amgen Is A Fantastic Dividend Growth Stock With A Weight-Loss Wild Card
Jun 04Amgen Stock: Poised To Break Out (Technical Analysis)
May 21Is Amgen Inc. (NASDAQ:AMGN) Trading At A 41% Discount?
May 04Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet
May 01Amgen: The Giant With An Impressive Pipeline
Apr 15Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Apr 01Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock
Mar 31Amgen Will Benefit From Increased Medical Spending
Mar 12Amgen: A Good Dividend Growth Stock For The Watch List
Mar 04Amgen's (NASDAQ:AMGN) Shareholders May Want To Dig Deeper Than Statutory Profit
Feb 21Pinning Down Amgen Inc.'s (NASDAQ:AMGN) P/E Is Difficult Right Now
Feb 16Amgen: Weight Loss Drug Candidate Debate A Red Herring - Buying The Dip Advisable
Feb 08Amgen: Accelerating The Business And Dividend Growth
Jan 29Is Amgen Inc. (NASDAQ:AMGN) Trading At A 44% Discount?
Jan 29Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks
Jan 22Is Amgen (NASDAQ:AMGN) A Risky Investment?
Dec 28Here's Why Amgen (NASDAQ:AMGN) Has Caught The Eye Of Investors
Dec 13Stability and Growth of Payments
Fetching dividends data
Stable Dividend: AMGN's dividends per share have been stable in the past 10 years.
Growing Dividend: AMGN's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Amgen Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (AMGN) | 3.1% |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.3% |
| Industry Average (Biotechs) | 2.3% |
| Analyst forecast (AMGN) (up to 3 years) | 3.6% |
Notable Dividend: AMGN's dividend (3.13%) is higher than the bottom 25% of dividend payers in the US market (1.38%).
High Dividend: AMGN's dividend (3.13%) is low compared to the top 25% of dividend payers in the US market (4.32%).
Earnings Payout to Shareholders
Earnings Coverage: With its high payout ratio (112.6%), AMGN's dividend payments are not well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: At its current cash payout ratio (77%), AMGN's dividend payments are covered by cash flows.